19 September 2025 - Most-Read Articles of the Year (So Far)

In today’s edition of The Daily Dose, we spotlight the articles that have resonated most with our readers in 2025 – from shifting drug pricing policy in the US, to the first joint clinical assessments under the EU HTA Regulation.

This selection also highlights timely perspectives on health equity in cancer care, the need to factor market access into investment strategies, and the latest developments in real-world evidence for HTA.

📘 Catch up on the most-read articles so far:

🔗 Trump executive order overturns innovative Medicare and Medicaid drug pricing models

🔗 European Commission releases details of first joint clinical assessments

🔗 WEBINAR: Bridging gaps in cancer care: tackling social drivers of health to improve access and outcomes

🔗 The need to consider market access for pharmaceutical investment decisions: a primer

🔗 R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19